Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Share-based Compensation (2020 - 2025)

Historic Share-based Compensation for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $8.0 million.

  • Treace Medical Concepts' Share-based Compensation rose 124.05% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.8 million, marking a year-over-year increase of 2472.42%. This contributed to the annual value of $30.6 million for FY2024, which is 7636.58% up from last year.
  • Per Treace Medical Concepts' latest filing, its Share-based Compensation stood at $8.0 million for Q3 2025, which was up 124.05% from $9.6 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Share-based Compensation ranged from a high of $9.6 million in Q2 2025 and a low of $402000.0 during Q1 2021
  • Over the past 5 years, Treace Medical Concepts' median Share-based Compensation value was $3.6 million (recorded in 2023), while the average stood at $4.5 million.
  • Per our database at Business Quant, Treace Medical Concepts' Share-based Compensation surged by 57120.0% in 2021 and then surged by 124.05% in 2025.
  • Over the past 5 years, Treace Medical Concepts' Share-based Compensation (Quarter) stood at $1.3 million in 2021, then skyrocketed by 91.03% to $2.5 million in 2022, then surged by 137.73% to $5.9 million in 2023, then soared by 45.69% to $8.6 million in 2024, then dropped by 6.51% to $8.0 million in 2025.
  • Its Share-based Compensation stands at $8.0 million for Q3 2025, versus $9.6 million for Q2 2025 and $8.7 million for Q1 2025.